CRISPR Market 2018 Size, Share, Development Status and Outlook by Players Till 2025

Summary:- (CRISPR Market Size Study by Application(Genome Editing, Genetic Engineering, Gene Library, CRISPR Plasmid, Human Stem cells, Genetically Modified Organism, Cell Line Engineering), by End-User (Biotechnology Companies, Pharmaceutical Companies, Academic Institutes, Research & Development Institutes) and Regional Forecast 2017-2025 USD Billion and Million Units)

Global CRISPR Market to reach USD 6000 million by 2025.

Request a Sample Report! Download a PDF sample copy@

Global CRISPR market is valued approximately USD 248 million in 2015. The growth is primarily driven by the rising demand for drug discovery and a significant rise in research spending. Further, increasing prevalence of genetic disorders due to late pregnancies and changing lifestyle patterns have drawn the significant attention of the researchers towards this emerging technology.

Due to easy availability of gene editing tools and cost-effectiveness, the technology has the highest adoption Gene Editing application. Some more applications include Genetic Engineering, Cell Line Engineering, and others. However, these applications still have restricted use due to some ethical issues. The total market revenue has been broadly segmented into application segment, end-user segment, and geography. Each of the segments is further divided as follows:

Genome Editing
Genetic Engineering
Gene Library
CRISPR Plasmid
Human Stem Cells
Genetically Modified Crops (GMO)
Cell Line Engineering

End User:
Biotechnology Companies
Pharmaceutical Companies
Academic Institutes
Research & Development Institutes

North America, U.S., Canada, Europe, UK, Germany, Asia Pacific, China, India, Japan, Latin America, Brazil, Mexico, Rest of the World

To Make an Enquiry on Report @

Among end-user segment Biotechnology firms and Research & Development Institutes currently captures more than 60% of total revenue share. High investments from these end-user segments are the primary driving force for the adoption this emerging technology. However, during over forecast period, Pharmaceutical firms are expected to witness highest growth rate. Significant developments in the field of pharmaceutical biotechnology are expected to generate huge opportunities in coming years.

The global market is dominated by North America region followed by Asia Pacific. The rising prevalence of infertility and genetic disorders in the Asia Pacific region are the primary driving factors. Agriculture and Animal breeding are the emerging applications in the Asian countries. North America captures approximately 38% of the total revenue share in 2015. Europe is also an emerging region for the development of this technology.

Some of the major players involved in the research and development of CRISPR market are; Thermo Fisher Scientific, Editas Medicine, Caribou Biosciences, Inc., CRISPR Therapeutics A, Intellia Therapeutics, Inc., Cellectis, Horizon Discovery PLC, Sigma-Aldrich Corporation, Precision BioSciences, GenScript Corporation, Sangamo Therapeutics, Inc. (SGMO), Lonza Group Limited, Integrated DNA Technologies, New England Biolabs, OriGene Technologies, Inc,.Transposagen Biopharmaceuticals, Inc

Major Point from Table of Content:

Chapter 1. Research Methodology
Chapter 2. Global CRISPR Market Definition & Scope
Chapter 3. Executive Summary
Chapter 4. Global CRISPR Industry Dynamics
Chapter 5. Global CRISPR Market by Application
Chapter 6. Global CRISPR Market by End User
Chapter 7. Global CRISPR Market, Regional Analysis
Chapter 8. Competitive Intelligence
8.1. Company Market Share (Subject to Data Availability)
8.2. Top Market Strategies
8.3. Company Profiles
8.3.1. Thermo Fisher Scientific Overview Financial (Subject to Data Availability) Product Summary Recent Developments
8.3.2. Editas Medicine
8.3.3. Caribou Biosciences, Inc.
8.3.4. CRISPR Therapeutics AG
8.3.5. Intellia Therapeutics, Inc.
8.3.6. Cellectis
8.3.7. Horizon Discovery PLC
8.3.8. Sigma-Aldrich Corporation
8.3.9. Precision BioSciences, Inc.
8.3.10. GenScript Corporation
8.3.11. Sangamo Therapeutics, Inc. (SGMO)
8.3.12. Lonza Group Limited
8.3.13. Integrated DNA Technologies
8.3.14. New England Biolabs
8.3.15. OriGene Technologies, Inc.
8.3.16. Transposagen Biopharmaceuticals, Inc

Read more…

Browse full report@

About Us:

Orbis Research ( is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.

Contact Us:

Hector Costello

Senior Manager – Client Engagements

4144N Central Expressway,

Suite 600, Dallas,

Texas – 75204, U.S.A.

Phone No: +1 (214) 884-6817; +912064101019

Email ID:


Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s